Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma
AIDS Malignancy Consortium
AIDS Malignancy Consortium
City of Hope Medical Center
University of California, San Francisco
Virginia Commonwealth University
Abramson Cancer Center at Penn Medicine
Medical University of South Carolina
Case Comprehensive Cancer Center
Duke University
City of Hope Medical Center
Roswell Park Cancer Institute
Rutgers, The State University of New Jersey